REMINDER: Our focusIR Investor Webinar takes place TONIGHT with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,807.50
Bid: 1,807.00
Ask: 1,808.00
Change: -2.50 (-0.14%)
Spread: 1.00 (0.055%)
Open: 1,805.00
High: 1,808.50
Low: 1,797.00
Prev. Close: 1,810.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London open: Investors turn cautious ahead of FOMC minutes

Wed, 20th Nov 2013 08:19

- Bernanke comments in focus ahead of FOMC minutes- Telecom Plus buys back businesses from Npower- Diageo CEO warns of 'uncertain' global economytechMARK 2,637.85 -0.24%FTSE 100 6,687.39 -0.16%FTSE 250 15,243.72 -0.14%UK stocks declined on Wednesday as investors adopted a cautious approach ahead of the release of the minutes from the latest Federal Reserve policy meeting this evening.The Federal Open Market Committee (FOMC) will release details of its October meeting this afternoon as markets wait to hear about the central bank's decision to maintain its stimulus programme last month.However, comments from Fed Chairman Ben Bernanke last night were in focus this morning after he reiterated that any tapering of asset purchases remains dependent on incoming economic data, as he held back from shedding any light on the timetable for an impending withdrawal."This comes before the FOMC meetings minutes will be released later today which will undoubtedly lead to volatility as investors attempt to decipher the underlying sentiment of the FOMC," said Alex Conroy, Financial Sales Trader at Spreadex.Retail sales, consumer price inflation and existing-home sales data is also due out today from the US this afternoon. Meanwhile, investors closer to home will be watching closely for the release of the minutes from the Bank of England's latest policy meeting.Telecom Plus soars after H1 results, acquisitionsUtilities reseller Telecom Plus was a high riser this morning after agreeing to pay £218m to buy back two gas and electricity supply businesses from Npower which it sold in 2006. The announcement came as the firm delivered a 17% increase in revenues in the first half, as profits rose 10.1%.Drinks group Diageo was under the weather after Chief Executive Ivan Menezes was reported as saying that the "uncertain" macro environment will continue to limit sales growth. Sector peer SABMiller was also out of favour this morning.Airline group easyJet was extending gains made yesterday after the company delivered a 51% increase in annual profits and unveiled an unexpected special dividend to shareholders.GlaxoSmithKline rose after completing the partial sale of Aspen Pharmacare, raising gross proceeds of 7.06bn South African rand ($695m).Engineering and construction firm Kentz was higher after being awarded a $190m contract with Qatar Petroleum for services on 775 wells across the Dukhan Oilfield in Qatar, extending the firms' long-standing relationship which started back in 1997.FTSE 100 - RisersAberdeen Asset Management (ADN) 487.80p +2.65%easyJet (EZJ) 1,367.00p +1.64%Pearson (PSON) 1,348.00p +1.43%London Stock Exchange Group (LSE) 1,593.00p +1.34%British Sky Broadcasting Group (BSY) 835.00p +1.21%Travis Perkins (TPK) 1,743.00p +1.04%William Hill (WMH) 364.80p +0.97%Royal Bank of Scotland Group (RBS) 330.70p +0.95%Shire Plc (SHP) 2,824.00p +0.86%Persimmon (PSN) 1,193.00p +0.68%FTSE 100 - FallersRexam (REX) 494.50p -1.79%Vodafone Group (VOD) 228.05p -1.72%Diageo (DGE) 1,999.50p -1.43%Weir Group (WEIR) 2,185.00p -1.27%Tate & Lyle (TATE) 811.00p -1.22%Hammerson (HMSO) 509.00p -1.17%Centrica (CNA) 338.10p -1.14%Intertek Group (ITRK) 3,067.00p -1.13%Sainsbury (J) (SBRY) 407.50p -1.02%Meggitt (MGGT) 501.50p -0.99%FTSE 250 - RisersTelecom Plus (TEP) 1,711.00p +13.54%Perform Group (PER) 443.80p +3.21%International Personal Finance (IPF) 591.50p +2.69%Kentz Corporation Ltd. (KENZ) 556.00p +2.58%BH Global Ltd. USD Shares (BHGU) 11.91 +1.79%Barratt Developments (BDEV) 326.80p +1.78%Telecity Group (TCY) 683.00p +1.64%Lancashire Holdings Limited (LRE) 804.00p +1.45%Devro (DVO) 310.90p +1.44%KCOM Group (KCOM) 104.40p +1.36%FTSE 250 - FallersHenderson Group (HGG) 216.90p -1.86%Centamin (DI) (CEY) 48.98p -1.84%Spirent Communications (SPT) 103.90p -1.70%Dunelm Group (DNLM) 879.00p -1.68%Bodycote (BOY) 608.50p -1.62%African Barrick Gold (ABG) 188.60p -1.62%Hikma Pharmaceuticals (HIK) 1,194.00p -1.57%Great Portland Estates (GPOR) 562.00p -1.40%Witan Inv Trust (WTAN) 650.50p -1.36%Afren (AFR) 158.90p -1.30%BC
More News
13 Feb 2024 12:06

LONDON MARKET MIDDAY: Stocks fall but pound up before US data

(Alliance News) - Stock prices in London were on the decline on Tuesday afternoon, with sentiment tetchy ahead of a US inflation report later.

Read more
13 Feb 2024 09:45

Citi ups recommendation on GSK to 'buy'

(Sharecast News) - Citi has upgraded its rating on vaccines and drugs blue chip GSK to 'buy' while also boosting its earnings estimates.

Read more
13 Feb 2024 09:32

LONDON BROKER RATINGS: Citi lifts GSK; Shore likes XPS Pensions

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
13 Feb 2024 07:45

LONDON BRIEFING: "Record" Tui quarter; Ultimate Products eyes payouts

(Alliance News) - London's FTSE 100 is to open ever-so-slightly lower on Tuesday, with trade set to be nervy ahead of the afternoon's US inflation data.

Read more
12 Feb 2024 17:11

London close: Stocks finish higher after very quiet Monday

(Sharecast News) - London markets managed modest gains by the close of a subdued trading session on Monday, with no significant corporate or economic catalysts driving movements.

Read more
12 Feb 2024 12:04

LONDON MARKET MIDDAY: FTSE 100 underperforms as European peers rise

(Alliance News) - London's FTSE 100 underwhelmed on Monday, with some of its largest constituents pulling it lower, while indices in Europe were on the up on favourable comments on interest rate cuts by a European Central Bank official.

Read more
12 Feb 2024 08:35

TOP NEWS: GSK's bepirovirsen receives US FDA fast track designation

(Alliance News) - GSK PLC on Monday said that the US health watchdog granted fast track designation for its bepirovirsen treatment for chronic hepatitis B.

Read more
12 Feb 2024 07:50

LONDON BRIEFING: Tritax Big Box, UK Commercial Property agree merger

(Alliance News) - Equities in London are called to open higher on Monday, with inflation readings from the US and UK on the horizon, which could drive equity market sentiment during the remainder of the week.

Read more
12 Feb 2024 07:21

GSK gets FDA fast track for chronic hepatitis B treatment

(Sharecast News) - GSK announced on Monday that bepirovirsen, an investigational antisense oligonucleotide (ASO) aimed at treating chronic hepatitis B (CHB), had been granted fast track designation by the US Food and Drug Administration (FDA).

Read more
9 Feb 2024 09:15

LONDON BROKER RATINGS: Deutsche Bank cuts AstraZeneca to 'sell'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
6 Feb 2024 08:51

TOP NEWS: GSK reports positive news on trio of high profile products

(Alliance News) - GSK PLC on Tuesday delivered a triple dose of positive updates on some of its leading products, Arexvy, Shingrix and Blencep.

Read more
6 Feb 2024 07:47

LONDON BRIEFING: BP promises buyback despite drop in profit

(Alliance News) - Stocks in London are called to open higher, ahead of a slew of construction purchasing managers' index readings from the eurozone, the UK and Germany.

Read more
6 Feb 2024 07:23

GSK reports positive myeloma trial results, progresses vaccine applications

(Sharecast News) - GSK reported progress in its trial of a myeloma treatment on Tuesday, as well as regulatory progress around its shingles vaccine in China and its RSV vaccine in the United States.

Read more
1 Feb 2024 09:27

TOP NEWS: GSK maintains "vigorous" defence after settling Zantac case

(Alliance News) - GSK PLC on Thursday insisted upon its scientific integrity, after reaching another settlement in ongoing litigation over alleged links between its heartburn drug and cancer.

Read more
1 Feb 2024 09:11

GSK settles Zantac case in California without admitting liability

(Sharecast News) - GSK announced on Thursday that it had reached a confidential settlement to effectively resolve the legal case over Zantac filed in a California state court.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.